市場調査レポート

商品コード

1319999

変形性関節症治療薬市場：解剖、薬物タイプ、投与経路、購買パターン、流通チャネル別-2023～2030年の世界予測

Osteoarthritis Therapeutics Market by Anatomy, Drug Type, Route of Administration, Purchasing Pattern, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 749,867円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 907,767円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,065,667円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,381,467円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.90円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

変形性関節症治療薬の世界市場は大きく成長すると予測され、2023年には79億198万米ドルが予測され、CAGRは10.32%、2030年には157億8,661万米ドルに達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の変形性関節症治療薬市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.変形性関節症治療薬の世界市場規模および予測は？

2.予測期間中、世界の変形性関節症治療薬市場を形成するCOVID-19の阻害要因と影響は？

3.変形性関節症治療薬の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.変形性関節症治療薬の世界市場における競争戦略は？

5.変形性関節症治療薬の世界市場における技術動向と規制の枠組みは？

6.変形性関節症治療薬の世界市場における主要ベンダーの市場シェアは？

7.変形性関節症治療薬の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 世界中で変形性関節症の有病率が上昇
  - 低侵襲外科手術に対する潜在的な需要
  - 世界中で高齢者人口の増加とスポーツ傷害の増加
- 抑制要因
  - NSAIDの副作用に関する懸念
- 機会
  - 変形性関節症に対する新たな医薬品治療法
  - 変形性関節症分野での継続的な研究開発
  - 変形性関節症の治療に対する政府の支援の増加
  - 新興国における一人当たり所得当たりの医療支出の増加
- 課題
  - 非薬物疼痛管理療法の急速な導入
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章変形性関節症治療薬市場：解剖別

イントロダクション
手の変形性関節症
変形性股関節症
変形性膝関節症
変形性小関節症

第7章変形性関節症治療薬市場：薬物タイプ別

イントロダクション
鎮痛剤
- アセトアミノフェン
- デュロキセチン
コルチコステロイド
非ステロイド性抗炎症薬
- アスピリン
- ジクロフェナク
- イブプロフェン
- ナプロキセン
関節内補充療法剤

第8章変形性関節症治療薬市場：投与経路別

イントロダクション
経口
非経口
局所

第9章変形性関節症治療薬市場：購入パターン別

イントロダクション
市販薬
処方薬

第10章変形性関節症治療薬市場：流通チャネル別

イントロダクション
病院薬局
オンライン薬局
小売薬局

第11章南北アメリカの変形性関節症治療薬市場

イントロダクション
アルゼンチン
ブラジル
カナダ
メキシコ
米国

第12章アジア太平洋地域の変形性関節症治療薬市場

イントロダクション
オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第13章欧州・中東・アフリカの変形性関節症治療薬市場

イントロダクション
デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第14章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第15章掲載企業一覧

第16章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2022 VS 2030
FIGURE 3. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2022 VS 2030 (%)
FIGURE 5. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2022 VS 2030 (%)
FIGURE 6. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 7. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2022 VS 2030 (%)
FIGURE 8. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 9. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 10. OSTEOARTHRITIS THERAPEUTICS MARKET DYNAMICS
FIGURE 11. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. OSTEOARTHRITIS THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 21. OSTEOARTHRITIS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. OSTEOARTHRITIS THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 5. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SMALL JOINT OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 10. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 11. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DULOXETINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 16. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DICLOFENAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NAPROXEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY VISCOSUPPLEMENTATION AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 23. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ORAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PARENTERAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TOPICAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 27. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 56. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 57. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 58. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 59. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 61. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 63. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 65. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 66. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 68. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 93. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 94. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 95. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 96. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 98. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 100. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 101. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 102. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 103. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 105. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 114. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 115. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 116. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 117. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 119. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 156. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 157. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 158. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 159. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 161. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 178. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 179. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 180. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 181. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 183. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 185. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 186. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 187. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 188. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 190. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 192. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 194. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 195. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 197. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 199. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 201. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 202. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 203. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 204. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 206. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 207. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 208. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 209. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 210. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 211. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 220. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 221. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 222. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 223. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 225. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 241. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 242. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 243. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 244. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 245. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 246. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 248. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 249. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 250. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 251. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 252. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 253. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 255. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 256. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 257. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 258. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 259. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 260. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 283. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 284. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 285. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 286. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 288. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 304. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 305. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 306. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 307. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MIL

Product Code: MRR-DD6333AE50D7

The Global Osteoarthritis Therapeutics Market is forecasted to grow significantly, with a projected USD 7,901.98 million in 2023 at a CAGR of 10.32% and expected to reach a staggering USD 15,786.61 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Osteoarthritis Therapeutics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Osteoarthritis Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Anatomy, market is studied across Hand Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, and Small Joint Osteoarthritis. The Hand Osteoarthritis is projected to witness significant market share during forecast period.

Based on Drug Type, market is studied across Analgesics, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs, and Viscosupplementation Agents. The Analgesics is further studied across Acetaminophen and Duloxetine. The Nonsteroidal Anti-inflammatory Drugs is further studied across Aspirin, Diclofenac, Ibuprofen, and Naproxen. The Nonsteroidal Anti-inflammatory Drugs is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across Oral Route, Parenteral Route, and Topical Route. The Parenteral Route is projected to witness significant market share during forecast period.

Based on Purchasing Pattern, market is studied across Over-the-Counter Drugs and Prescription Drugs. The Over-the-Counter Drugs is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Hospital Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Osteoarthritis Therapeutics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Osteoarthritis Therapeutics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Osteoarthritis Therapeutics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Osteoarthritis Therapeutics Market?

4. What is the competitive strategic window for opportunities in the Global Osteoarthritis Therapeutics Market?

5. What are the technology trends and regulatory frameworks in the Global Osteoarthritis Therapeutics Market?

6. What is the market share of the leading vendors in the Global Osteoarthritis Therapeutics Market?

7. What modes and strategic moves are considered suitable for entering the Global Osteoarthritis Therapeutics Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Osteoarthritis Therapeutics Market, by Anatomy, 2022 vs 2030
4.3. Osteoarthritis Therapeutics Market, by Drug Type, 2022 vs 2030
4.4. Osteoarthritis Therapeutics Market, by Route of Administration, 2022 vs 2030
4.5. Osteoarthritis Therapeutics Market, by Purchasing Pattern, 2022 vs 2030
4.6. Osteoarthritis Therapeutics Market, by Distribution Channel, 2022 vs 2030
4.7. Osteoarthritis Therapeutics Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of osteoarthritis across the globe
  - 5.1.1.2. Potential demand for minimally invasive surgical procedures
  - 5.1.1.3. Growing geriatric population coupled with increasing sports injury worldwide
- 5.1.2. Restraints
  - 5.1.2.1. Concern associated with adverse effects of NSAID
- 5.1.3. Opportunities
  - 5.1.3.1. Emerging pharmaceuticals therapies for osteoarthritis
  - 5.1.3.2. Ongoing research and development in the osteoarthritis field
  - 5.1.3.3. Increasing governments supports towards the osteoarthritis treatment
  - 5.1.3.4. Rising healthcare expenditure per capita income in the emerging economies
- 5.1.4. Challenges
  - 5.1.4.1. Rapid adoption of non-drug pain management therapies
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Osteoarthritis Therapeutics Market, by Anatomy

6.1. Introduction
6.2. Hand Osteoarthritis
6.3. Hip Osteoarthritis
6.4. Knee Osteoarthritis
6.5. Small Joint Osteoarthritis

7. Osteoarthritis Therapeutics Market, by Drug Type

7.1. Introduction
7.2. Analgesics
- 7.2.1. Acetaminophen
- 7.2.2. Duloxetine
7.3. Corticosteroids
7.4. Nonsteroidal Anti-inflammatory Drugs
- 7.4.1. Aspirin
- 7.4.2. Diclofenac
- 7.4.3. Ibuprofen
- 7.4.4. Naproxen
7.5. Viscosupplementation Agents

8. Osteoarthritis Therapeutics Market, by Route of Administration

8.1. Introduction
8.2. Oral Route
8.3. Parenteral Route
8.4. Topical Route

9. Osteoarthritis Therapeutics Market, by Purchasing Pattern

9.1. Introduction
9.2. Over-the-Counter Drugs
9.3. Prescription Drugs

10. Osteoarthritis Therapeutics Market, by Distribution Channel

10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies

11. Americas Osteoarthritis Therapeutics Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Osteoarthritis Therapeutics Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Osteoarthritis Therapeutics Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

変形性関節症治療薬市場：解剖、薬物タイプ、投与経路、購買パターン、流通チャネル別-2023～2030年の世界予測

Osteoarthritis Therapeutics Market by Anatomy, Drug Type, Route of Administration, Purchasing Pattern, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 変形性関節症治療薬市場：解剖別

第7章 変形性関節症治療薬市場：薬物タイプ別

第8章 変形性関節症治療薬市場：投与経路別

第9章 変形性関節症治療薬市場：購入パターン別

第10章 変形性関節症治療薬市場：流通チャネル別

第11章 南北アメリカの変形性関節症治療薬市場

第12章 アジア太平洋地域の変形性関節症治療薬市場

第13章 欧州・中東・アフリカの変形性関節症治療薬市場

第14章 競合情勢

第15章 掲載企業一覧

第16章 付録